Matches in Wikidata for { <http://www.wikidata.org/entity/Q37821894> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q37821894 description "article científic" @default.
- Q37821894 description "article scientifique" @default.
- Q37821894 description "articolo scientifico" @default.
- Q37821894 description "artigo científico" @default.
- Q37821894 description "artículu científicu espublizáu en 2011" @default.
- Q37821894 description "bilimsel makale" @default.
- Q37821894 description "bài báo khoa học" @default.
- Q37821894 description "scientific article published on January 2011" @default.
- Q37821894 description "vedecký článok" @default.
- Q37821894 description "vetenskaplig artikel" @default.
- Q37821894 description "videnskabelig artikel" @default.
- Q37821894 description "vědecký článek" @default.
- Q37821894 description "wetenschappelijk artikel" @default.
- Q37821894 description "wissenschaftlicher Artikel" @default.
- Q37821894 description "наукова стаття, опублікована в січні 2011" @default.
- Q37821894 description "научни чланак" @default.
- Q37821894 description "գիտական հոդված հրատարակված 2011 թվականի հունվարին" @default.
- Q37821894 description "مقالة علمية نشرت في يناير 2011" @default.
- Q37821894 name "Sipuleucel-T for prostate cancer: the immunotherapy era has commenced" @default.
- Q37821894 name "Sipuleucel-T for prostate cancer: the immunotherapy era has commenced" @default.
- Q37821894 name "Sipuleucel-T for prostate cancer: the immunotherapy era has commenced" @default.
- Q37821894 type Item @default.
- Q37821894 label "Sipuleucel-T for prostate cancer: the immunotherapy era has commenced" @default.
- Q37821894 label "Sipuleucel-T for prostate cancer: the immunotherapy era has commenced" @default.
- Q37821894 label "Sipuleucel-T for prostate cancer: the immunotherapy era has commenced" @default.
- Q37821894 prefLabel "Sipuleucel-T for prostate cancer: the immunotherapy era has commenced" @default.
- Q37821894 prefLabel "Sipuleucel-T for prostate cancer: the immunotherapy era has commenced" @default.
- Q37821894 prefLabel "Sipuleucel-T for prostate cancer: the immunotherapy era has commenced" @default.
- Q37821894 P1433 Q37821894-F8CD77A7-4C65-40A2-9299-0BD015675270 @default.
- Q37821894 P1476 Q37821894-384DFB1B-CEB2-4402-8F84-9D06DB0447B7 @default.
- Q37821894 P2093 Q37821894-2BD08F29-C73D-400A-A217-2F5B5E010BE8 @default.
- Q37821894 P2093 Q37821894-387A2FBD-718B-4E1F-B5E2-BF47E66EBA87 @default.
- Q37821894 P2860 Q37821894-21627CE9-6E7A-4B4C-B7E0-0C61C886C62F @default.
- Q37821894 P2860 Q37821894-59B5324D-0371-41DF-BCED-A38869B364C4 @default.
- Q37821894 P2860 Q37821894-5CB07FD3-716C-4B96-8F1D-0357492E56D2 @default.
- Q37821894 P2860 Q37821894-78FFFEBF-2072-4627-89EB-B11C0E1D1D14 @default.
- Q37821894 P2860 Q37821894-A8B549EA-773E-435E-B170-08CED4A9BAED @default.
- Q37821894 P2860 Q37821894-D354D9BB-964B-47E0-BB14-1AE80799EB23 @default.
- Q37821894 P2860 Q37821894-DB648A45-EE26-4338-8869-8D8B76F44F7A @default.
- Q37821894 P2860 Q37821894-FE090A8D-041E-4C54-9726-11613C9E2252 @default.
- Q37821894 P304 Q37821894-D47DD904-61D5-46CC-B21F-1B534E0181BA @default.
- Q37821894 P31 Q37821894-870998a3-3b8d-47b0-a3a8-d5b21bc51028 @default.
- Q37821894 P31 Q37821894-F7CF1D49-C989-4CA0-9537-FAABF2EE3901 @default.
- Q37821894 P356 Q37821894-7C079782-A7D9-46C7-94BC-4FB90AFFAB0D @default.
- Q37821894 P407 Q37821894-16FD6D5E-46A1-481B-9D0A-75EE6E74496F @default.
- Q37821894 P433 Q37821894-402F027A-D587-4E2E-A887-543C91EEEBA6 @default.
- Q37821894 P478 Q37821894-71662426-9599-49A1-B6B3-36BFFB3FA456 @default.
- Q37821894 P50 Q37821894-6ADF5E7F-D15A-4E3C-B4E4-21425D500DE3 @default.
- Q37821894 P577 Q37821894-53107848-69B0-4599-A204-79570CFC5C01 @default.
- Q37821894 P698 Q37821894-F42B3FF5-559E-4A98-897B-69270B586DD1 @default.
- Q37821894 P921 Q37821894-0C572282-D008-455D-A4CA-C540F17EE3F4 @default.
- Q37821894 P921 Q37821894-837E34A3-38DA-431A-88A2-377CA146FA3E @default.
- Q37821894 P356 ERA.10.180 @default.
- Q37821894 P698 21166508 @default.
- Q37821894 P1433 Q2999044 @default.
- Q37821894 P1476 "Sipuleucel-T for prostate cancer: the immunotherapy era has commenced" @default.
- Q37821894 P2093 "Carlo Buonerba" @default.
- Q37821894 P2093 "Giuseppe Di Lorenzo" @default.
- Q37821894 P2860 Q24632187 @default.
- Q37821894 P2860 Q27860648 @default.
- Q37821894 P2860 Q34543188 @default.
- Q37821894 P2860 Q37431076 @default.
- Q37821894 P2860 Q37756122 @default.
- Q37821894 P2860 Q43004667 @default.
- Q37821894 P2860 Q54718480 @default.
- Q37821894 P2860 Q55053398 @default.
- Q37821894 P304 "25-28" @default.
- Q37821894 P31 Q13442814 @default.
- Q37821894 P31 Q7318358 @default.
- Q37821894 P356 "10.1586/ERA.10.180" @default.
- Q37821894 P407 Q1860 @default.
- Q37821894 P433 "1" @default.
- Q37821894 P478 "11" @default.
- Q37821894 P50 Q30504810 @default.
- Q37821894 P577 "2011-01-01T00:00:00Z" @default.
- Q37821894 P698 "21166508" @default.
- Q37821894 P921 Q1427096 @default.
- Q37821894 P921 Q181257 @default.